rid4stat's profile picture. The CEO of Roak Consult. Specializes in quality data gathering, simple and complex data analysis and data engineering.

Ridwan Olaniran, PhD

@rid4stat

The CEO of Roak Consult. Specializes in quality data gathering, simple and complex data analysis and data engineering.

Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…


On the Oracle Properties of Bayesian Random Forest for Sparse High-Dimensional Gaussian Regression mdpi.com/2600774 #mdpimathematics via @MathematicsMDPI


Ridwan Olaniran, PhD hat repostet

New article (Vol. 190) The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC Cole Friedes et al. doi.org/10.1016/j.rado… thegreenjournal.com/article/S0167-…


Ridwan Olaniran, PhD hat repostet

📣Looking forward to the presentation at #ASH23 of the SPARTA Study, led by @FGIMEMA & @EORTC Leukemia & #QualityofLife Groups and investigating prevalence of lifestyle behaviours of long-term #AML survivors & associations with #HRQoL profile👇 #CancerResearch @ASH_hematology

🗓️This week at #ASH23, Prof Fabio Efficace will present the SPARTA Study, an international survivorship study by @FGIMEMA & @EORTC Leukemia & #QualityofLife Groups in long-term survivors of #acutemyeloidleukemia. More info👇 ash.confex.com/ash/2023/webpr… #AML #HRQoL @ASH_hematology

EORTC_QLG's tweet image. 🗓️This week at #ASH23, Prof Fabio Efficace will present the SPARTA Study, an international survivorship study by @FGIMEMA & @EORTC Leukemia & #QualityofLife Groups in long-term survivors of #acutemyeloidleukemia.

More info👇
ash.confex.com/ash/2023/webpr…

#AML #HRQoL

@ASH_hematology


Ridwan Olaniran, PhD hat repostet

@EORTC rolling out abstracts like hot cookies for Santa!

We are proud to inform you that 7 #IMMUcan abstracts were selected for the #ESMOImmuno23 Congress in Geneva, Switzerland. Read more: eortc.org/blog/2023/12/0… @IMMUcan @myESMO #CancerResearch #ClinicalTrials #Oncology #ImmunoOncology

EORTC's tweet image. We are proud to inform you that 7 #IMMUcan abstracts were selected for the #ESMOImmuno23 Congress in Geneva, Switzerland.  

Read more: eortc.org/blog/2023/12/0… @IMMUcan 

@myESMO #CancerResearch #ClinicalTrials #Oncology #ImmunoOncology


Ridwan Olaniran, PhD hat repostet

👋 Check out the final manuscript of “Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated NSCLC (ATTLAS, KCSG-LU19-04)” 👉 brnw.ch/21wF5GE #LCSM

🫁 Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated NSCLC Q:1,2 (ATTLAS, KCSG-LU19-04) ➡️ brnw.ch/21wDJ85 #ESMO23 #LCSM

JCO_ASCO's tweet image. 🫁 Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated NSCLC Q:1,2 (ATTLAS, KCSG-LU19-04) ➡️ brnw.ch/21wDJ85 #ESMO23 #LCSM


Ridwan Olaniran, PhD hat repostet

New article (Vol. 190) Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis Baijie Feng et al. doi.org/10.1016/j.rado… thegreenjournal.com/article/S0167-…


Loading...

Something went wrong.


Something went wrong.